Ace Men (539661)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹41.8 |
| Market Cap | ₹13.22 Cr |
| P/E Ratio | 0 |
| ROCE | -0.52% |
| ROE | -0.34% |
| Dividend Yield | 0% |
| Profit Growth | -200% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹84.4 — ₹107.14 |
| Sector | Retailing |
| Book Value | ₹3.09 |
Strengths
- Positive book value of ₹3.09 per share provides a modest nominal asset buffer.
- Latest quarter net loss is only ₹-0 Cr, so absolute cash burn is minuscule.
- Tiny ₹13 Cr market cap leaves theoretical room for a strategic/special-situation buyer if operations are revived.
Concerns
- Sales are ₹0 Cr and net profit is ₹-0 Cr; there is no visible operating engine.
- At ₹41.80, the stock trades at 13.53× book value (₹3.09) and below its 52-week low of ₹59.50, a falling-knife pattern.
- Piotroski F-score of 2/9, ROE -0.34%, ROCE -0.52%, and -200% profit growth point to deteriorating financial health.
- Zero dividend and zero earnings mean shareholders receive no compensation for the wait.
AI Analysis
Let me start with what I always ask: Can I understand the business, does it have a durable competitive advantage, and is the price low enough to compensate for risk? Ace Men, a ₹13 crore market-cap distributor, answers no. The latest quarter has sales of ₹0 crore and net profit of ₹-0 crore. A full-year profit growth of -200% and a reported P/E of 0.00 tell me there is no earnings engine to value. With book value at ₹3.09 and the share price at ₹41.80, I am being asked to pay 13.5 times book for a company that earns -0.34% ROE and -0.52% ROCE. That is not investing; that is hoping. Graham would say price is what you pay, value is what you get. Here the value is invisible. The Piotroski F-score is 2/9, among the weakest I have seen. The 52-week range is ₹59.50 to ₹107.14, and the shares trade below the low at ₹41.80; the market is sending a clear signal. There is no dividend, so I am not paid to wait. This is not a stalwart or a grower. It might be a turnaround candidate only if a credible business plan emerges, but there is nothing in these numbers to suggest revival. I would watch for revenue returning to a positive number, for any restructuring, and for management that holds meaningful skin in the game. Until I see sales, profits, and a sane valuation, this remains a speculator’s micro-cap, not a value investor’s choice. In the end, I prefer a wonderful company at a fair price, or a fair company at a wonderful price. Ace Men offers neither.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer